Skip to main content

Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome.

  • 2010-04
  • Annals of Allergy, Asthma & Immunology 104(4)
    • S. Woo
    • Ji-Yon Kim
    • Yong-Ju Lee
    • Nam-Shik Kim
    • Y. Hahn

Abstract

Background: Probiotics have been suggested to be useful in children with atopic eczema-dermatitis syndrome (AEDS).

Objective: To assess the clinical effect of Lactobacillus sakei supplementation in children with AEDS.

Methods: In a double-blind, placebo-controlled trial, children aged 2 to 10 years with AEDS with a minimum SCORing of Atopic Dermatitis (SCORAD) score of 25 were randomized to receive either daily L sakei KCTC 10755BP or daily placebo supplementation for 12 weeks. Changes in SCORAD scores and serum chemokine levels from baseline were evaluated.

Results: Eighty-eight children were enrolled, and 45 were allocated to probiotic treatment. Seventy-five children completed the study, with 4 dropouts in the probiotic group and 9 in the placebo group. At week 12, SCORAD total scores adjusted by pretreatment values were lower after probiotic treatment than after placebo treatment (P = .01). There was a 31% (13.1-point) improvement in mean disease activity with probiotic use compared with a 13% (5.2-point) improvement with placebo use (P = .008). Significant differences in favor of probiotic treatment were also observed in proportions of patients achieving improvement of at least 30% and 50%. Compared with placebo, probiotic administration was associated with lower pretreatment-adjusted serum levels of CCL17 and CCL27 (P =.03 for both), which were significantly correlated with SCORAD total score (r = 0.59 and 0.63, respectively; P < .001).

Conclusions: Supplementation of L sakei in children with AEDS was associated with a substantial clinical improvement and a significant decrease in chemokine levels, reflecting the severity of AEDS.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus sakei proBio65Improved Atopic Eczema-Dermatitis SymptomsBeneficial
Large
Lactobacillus sakei proBio65Reduced Serum Chemokine LevelsBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.